medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2010, Number 592

<< Back Next >>

Rev Med Cos Cen 2010; 67 (592)

Sindrome Hepatorrenal

Gallegos MA, Gómez VF

Language: Spanish
References: 13
Page: 139-144
PDF size: 332.88 Kb.


ABSTRACT

Hepatorenal syndrome (HRS) is a common complication of cirrhosis. It is characterized by renal failure and hemodynamic alterations. Renal failure is caused by intense vasoconstriction of the renal circulation. Nowadays, the diagnosis takes place by clinical and laboratory criteria after excluding any other possible cause of renal impairment. The hepatic transplant is the current treatment of choice; however, it is not always possible due to restrictions in the procedure. In the last years, new therapies have been implemented to improve renal function while the patient is waiting for a hepatic transplant.


REFERENCES

  1. Arroyo V. New Treatments for Hepatorenal Syndrome. Liver Transplantation, 2000; 6:287-289.

  2. Arroyo V, Terra C, Gines P. New Treatments of Hepatorenal Syndrome. Seminars in liver disease, 2006; 3: 254-264.

  3. Dagher L, Moore K. The hepatorenal syndrome. GUT, 2001; 49:729-737.

  4. Dagher L, Patch D, Marley R, Moore K, Burroughs A. Review article: phar-macological treatment of hepatorenal syndrome in cirrhotic patients. Aliment Pharmacol Ther, 2000; 14:515-521.

  5. Genzini T, Miranda F. Hepatorenal syndrome: an update. Sao Paulo Med J, 2007; 125:50-56.

  6. Ginès P, Guevara M, Arroyo V, Rodés J. Hepatorenal Syndrome. Lancet, 2003; 362: 1819–1827.

  7. Henriksen J et al. Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatol Int, 2008; 2:416-428.

  8. Moreau R, Lebrec D. Review article: hepatorenal syndrome – definitions and diagnosis. Aliment Pharmacol Ther, 2004; 20 (Suppl. 3): 24–28.

  9. Murray E. Hepatorenal Syndrome: Emerging Perspectives of Pathophy-siology and Therapy. Journal of the American Society of Nephrology, 1994; 4:1735-1753.

  10. Schepke M. Hepatorenal syndrome: current diagnostic and therapeutic concepts. Nephrol Dial Transplant, 2007; 22:viii2-viii4.

  11. Turban S, Thuluvath P, Atta M. Hepatorenal syndrome. World J Gastroenterol, 2007; 13:4046-4055.

  12. Wadei H, Mai M, Ahsan N, Gonwa T. Hepatorenal Syndrome: Pathophysiology and Management. Clin J Am Soc Nephrol, 2006; 1:1066-1079.

  13. Wilkinson S, Moore K, Arroyo V. Pathogenesis of ascites and hepatorenal syndrome. GUT Supplement, 1991; S12-S17.




2020     |     www.medigraphic.com